AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced
Apollo Endosurgery, Inc.: Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021
AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ( Apollo ) (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021 after the market closes. In conjunction with the release, Apollo will host a conference call at 3:30 p.m. CT / 4:30 p.m. ET to discuss the results. To join the call by telephone, please dial +1-973-528-0011. A live webcast of the conference call will be available online from the investor relations page of the Company s corporate website at www.apolloendo.com.
AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced
(2)
AUSTIN, TX / ACCESSWIRE / February 22, 2021 / Apollo Endosurgery, Inc. ( Apollo ) (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 after the market closes. In conjunction with the release, Apollo will host a conference call at 3:30 p.m. CT / 4:30 p.m. ET to discuss the results. To join the call by telephone, please dial +1-973-528-0011. A live webcast of the conference call will be available online from the investor relations page of the Company s corporate website at www.apolloendo.com.